1Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation[J].Nat Rev Immunol, 2008,8 : 958-969.
2Stein M, Keshav S, Harris N, et al. Interleukin 4 potently enhances murine maerophage mannose receptor activity: a marker of alternative immunologic macrophage activation[J].J Exp Med,1992, 176:287-292.
3Gordon S. Alternative activation of macrophages[J]. Nat Rev Immunol, 2003,3:23-35.
4Martinez FO, Helming L, Gordon S. Alternative activation of macrophages:an immunologic functional perspective[J].Annu Rev Immunol, 2009,27:451-483.
5Timmer AM, Nizet V. IKKI3/NF-κB and the miscreant macrophage[J]. J Exp Med,2008, 205:1655-1659.
6Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions[J]. Immunity, 2010,32:593- 604.
7Liu Y, Stewart KN, Bishop E, et al. Unique expression of suppressor of cytokine signaling 3 is essential for classical macrophage activation in rodents in vitro and in vivo[J]. J Immunol, 2008, 180:6270-6278.
8Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance [J].Nature, 2007,447 :1116- 1120.
9Cramer T, Yamanishi Y, Clausen BE, et al. HIF-1alpha is essential for myeloid cell mediated inflammation [J]. Cell, 2003,113:419.
10Ishii M, Wen H, Corsa CA, et al. Epigenetic regulation of the alternatively activated macrophage phenotype[J]. Blood, 2009 , 114:3244-3254.
